Morgan Stanley Put 7675 PX1 21.06.../ DE000MB818H4 /
29/05/2024 10:08:43 | Var.+0.049 | Denaro12:49:02 | Lettera12:49:02 | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
0.126EUR | +63.64% | 0.133 Quantità in denaro: 100,000 |
0.143 Quantità in lettera: 100,000 |
CAC 40 | 7,675.00 - | 21/06/2024 | Put |
GlobeNewswire
13:02
Jeito Capital announces the acquisition by Merck & Co (NYSE: MRK) of its portfolio company EyeBio fo...
GlobeNewswire
13:00
Host Hotels & Resorts Enters into Agreement to Acquire Turtle Bay Resort in Hawaii
GlobeNewswire
13:00
Kynexis Appoints Esteemed Scientific Advisory Board Members to Advance Precision Therapeutics for Br...
GlobeNewswire
13:00
Zentalis Pharmaceuticals Announces Appointment of Accomplished Oncology Drug Developer Luke Walker, ...
GlobeNewswire
13:00
Foundation Medicine and PMV Pharma Announce Collaboration to Develop Companion Diagnostic for Rezata...
GlobeNewswire
13:00
Predictive Oncology Announces CEO Raymond Vennare to Present at the BIO International Convention 202...
GlobeNewswire
13:00
Axsome Therapeutics Highlights Data on Solriamfetol Demonstrating Improvement in Cognitive Function ...
GlobeNewswire
13:00
Fractyl Health to Present New Preclinical Obesity Data from Rejuva® Platform at the American Diabete...
GlobeNewswire
13:00
TScan Therapeutics Receives FDA’s Regenerative Medicine Advanced Therapy (RMAT) Designation for its ...
GlobeNewswire
13:00
Scorpius Holdings Achieves 359% Year-Over-Year Increase in Revenue for the First Quarter of 2024